KAO JOHN E 4

What Happened John E. Kao, CEO of Alignment Healthcare, sold a total of 298,000 common shares in open‑market transactions on July 10, 2026, generating total proceeds of $5,919,361. The sales were reported as two blocks: 279,644 shares at a weighted‑average price of $19.81 (proceeds $5,540,363) and 18,356 shares at a weighted‑average price of $20.65 (proceeds $378,998). Both dispositions are coded as sales (S).

Key Details

• Transaction date: 2026-07-10; Form 4 filed: 2026-07-14 (within the two‑business‑day filing window).
• Prices/ranges: larger block weighted avg $19.81 (actual trades ranged $19.55–$20.54, per footnote); smaller block weighted avg $20.65 (actual trades ranged $20.55–$20.84). Reporting person can provide a breakdown of trades by price on request.
• Total shares sold: 298,000; total proceeds: $5,919,361.
• Footnotes: sales were made under a Rule 10b5‑1 plan adopted 11/21/2025 (F1). Some securities sold are held by the JEK Trust dated 2/8/2021, of which Mr. Kao is trustee (F3).
• Shares owned after the transaction are not provided in the supplied filing details.

Context These were open‑market sales executed under a pre‑established 10b5‑1 plan, which typically schedules trades in advance and is generally viewed as routine rather than an immediate signal of insider sentiment. Multiple executions produced weighted‑average prices; the filer offers to supply per‑trade price breakdowns if requested.